GlobeNewswire Inc | Jan 4, 2022 08:00AM EST

January 04, 2022

UPPSALA, Sweden, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Olink) (Nasdaq: OLK), today announced it will be virtually participating in the 40th Annual J.P. Morgan Healthcare Conference.

Jon Heimer, CEO, is scheduled to present on Wednesday, January 12th, 2022, at 9:00 am ET.

A live and archived webcast of the event will be available on the Investors section of the Companys website at https://investors.olink.com/investor-relations.

About OlinkOlink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.

For more information please contact:

IR Contact Jan Medina, CFAVP Investor Relations & Capital MarketsMobile: +1617802 4157jan.medina@olink.com

Media Contact Andrea PranderCorporate Communications ManagerMobile: + 46768775 275andrea.prander@olink.com